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Abstract 
 
Cardiovascular diseases (CVDs) are the major cause of disability and premature death all over 
the world. Annually, 17.5 million people die from CVDs, representing 30% of the total 
number of deaths. Despite established guidelines for the treatment of acute coronary 
syndrome, cardiac weakness, atrial fibrillation and CVD prevention, many patients remain 
inadequately treated, particularly in less developed nations. A brief overview of the 
development of CVDs, description of the current practice guidelines, and a cross sectional 
analyses of the status of CVD prevention and control in the Federation of Bosnia and 
Herzegovina is given. In the past 7 years, there has been a steady increase in deaths, where 
half of all deaths in the Federation of Bosnia and Herzegovina are attributed to CVDs. Deaths 
from the acute myocardial infarction had a rate of 91.0/100,000 inhabitants, a significant 
increase compared to 2010, when this rate was 69.2. The second leading cause of death, a 
stroke, with a rate of 87.1 showed a slight decrease compared to 2010, when it was 89.9. The 
third leading cause of death, heart failure, with a rate of 68.4, has a slight decrease compared 
to 2010, when the rate was 75.7. CVDs are the leading cause of mortality in Federation of 
Bosnia and Herzegovina, which, in addition to the large number of premature deaths, also 
causes major costs for the health sector and economy.  
Key words: cardiovascular disease, prevention, risk factors, monitoring, Bosnia and 
Herzegovina  
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Introduction   
Cardiovascular diseases (CVDs) are the major cause of disability and premature death all over 
the world, contributing significantly to the rising costs of health care (1,2). Around 17.5 
million people die from CVDs in the world annually, representing 30% of the total number of 
deaths (3,4). About 1.5 billion years of life are lost due to premature death and disability, and 
CVDs are responsible for 10%. In Europe, CVDs are responsible for a 4.9 million deaths 
annually, which is an average of 51% of all deaths (1,2).   
Despite established guidelines for the treatment of acute coronary syndrome, cardiac 
weakness, atrial fibrillation and CVD prevention, many patients remain inadequately treated, 
particularly in the southeastern Balkans. There have been sizable efforts to recognize CVD 
risk factors and enable timely diagnosis in Bosnia and Herzegovina through primary health 
care system (PHC) (5). The aim of this paper was to summarize established guidelines in the 
prevention and monitoring of CVDs and to compare it to the trends in Federation of Bosnia 
and Herzegovina, as well as to present the real challenges facing prevention and monitoring of 
CVDs in Federation of Bosnia and Herzegovina. 
Etiology and development of CVDs 
The basic cause of the CVDs development is atherosclerosis, which is the most common 
arterial disease characterized by the reduction in lumen of the blood vessel due to local plaque 
or atheroma thickening. Of the ten most common causes of death, six are related to heart and 
blood vessels as a result of atherosclerosis (10,11). Atherosclerosis begins in childhood, but 
the symptoms are not presented at the young age. Typically in the sixth decade of life, the 
symptoms appear and are exasperated with an increase in life expectancy. The most common 
risk factors for the development of atherosclerotic disease are hyperlipidemia, hypertension, 
smoking, diabetes, high fibrinogen, male and younger sex, menopause in women taking oral 
contraceptives or hormonal therapy only in the presence of other risk factors, increased 
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weight, elevated level homocysteine, physical activity, inheritance and immune response in 
some diseases (12,13). The consequences of atherosclerosis include: coronary or ischemic 
heart disease, in particular myocardial infarction, cerebrovascular disease and cerebrovascular 
events (80% of all myocardial infarction and stroke due to atherosclerosis), narrowing or 
blocking of peripheral arteries, carotid arteries, especially leg, which can lead to gangrene 
development (14,15). 
 
Historical perspective on the development of CVD international 
practice guidelines  
The CVD prevention guidelines has been published in numerous documents of internationally 
relevant organizations and associations including World Health Organization, World Heart 
Federation, European Society of Cardiology and Other Societies on CVD Prevention in 
Clinical Practice, National Cardiac Societies and others (16-18). The first recommendations of 
the European Society for the Prevention of CVD from 1994 reflected the need for consensus 
by the European Society of Atherosclerosis and the European Society of Hypertension and 
were aimed at assessing the overall risk for primary prevention of CVD. The revision was 
published in 1998 by involvement of these societies with the European Society of General 
Practitioners / Family Medicine, the European Heart Network (EHN) and the International 
Association of Behavioral Medicine. Realizing that even a wider field of expertise is needed, 
the European Association for the Study of Diabetes (EASD) and the International Diabetes 
Federation (IDF) have been included in the follow-up to the recommendations on CVDs, and 
the focus has been placed on the concept of the overall cardiovascular risk using the SCORE 
database (Systematic Coronary Risk Evaluation project).  
Specific risk tables based on SCORE have been made for low- and high-risk countries and are 
widely accepted across Europe. The concept of primary and secondary prevention was 
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replaced by the knowledge that atherosclerosis is a continuous process. By incorporating the 
European Stroke Initiative in 2007, a fourth set of recommendations for the CVD was 
published by the combined effort of nine scientific bodies and the European Association for 
Cardiovascular Prevention and Rehabilitation within the ESC. In these recommendations, 
special emphasis was placed on the prevention of CVDs at the level of Primary Health Care 
(PHC) and counseling on lifestyle changes, resulting in a revised approach to CVDs among 
young people using a relative risk-based table based on SCORE (17,18). The revised fifth set 
of the CVDs recommendations focused on enforcing the dissemination of guidelines at the 
national level, the formation of national associations and the implementation of 
recommendations in clinical practice.  
The European Society of Cardiology and the European Heart Network, with the support of the 
European Commission and the World Health Organization, have developed the first European 
Heart Health Charter designed to prevent CVD (CVD) in Europe 
(http://www.heartcharter.org). This public health document has been approved by most EU 
members by defining healthy life choices and orientations: without the use of tobacco, 
sufficient physical activity: at least 30 minutes five times a week, healthy eating habits, 
without excessive nutrition, blood pressure below 140/90 mm / Hg, cholesterol <5 mmol (190 
mg/dl), normal glucose metabolism and avoiding excessive stress (21). 
The latest European guidelines were developed in 2016 by the Sixth European Joint Working 
Group and ten professional associations, entitled «2016 European guidelines on CVD 
prevention in clinical practice». For the purpose of simplification, the guidelines used a 
classification system based on the levels of evidence (A – evidence from meta-analysis, B – 
evidence from single randomized clinical trial , and C – opinion of experts) and classes of 
recommendation (I – general agreement that the procedure is beneficial, II – conflicting 
evidence, III – general agreement that the procedure is not beneficial). It was developed for 
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health professionals as a tool for better communication with individuals about their 
cardiovascular risk, benefits from a healthy lifestyle, and early modification of their 
cardiovascular risk. Compared to the previous ones, these new guidelines placed a greater 
emphasis on the population approach, ie. women, young people and ethnic minorities. A 
lifelong approach to the risk of developing CVD is important because the risk for CVD and 
prevention is dynamic and continuous, as patients’ age and / or accumulate comorbidities. 
This means that, in addition to improving life and reducing risk factors in patients with 
established CVDs and those with an increased risk of developing CVD, healthy people of all 
ages should be encouraged to adopt a healthy lifestyle (22). 
Finally, it is important to note that the last decade of prevention and control of the CVDs has 
become a global public health challenge. For example, in 2011 thirty eight contributors signed 
the Moscow Declaration on Non communicable Diseases (NCD) as well as the UN Political 
Declaration on NCDs, which emphasized the urgency regarding the scale of the issues such as 
CVD, cancers, diabetes and chronic lung disease (5,6). Consequently, in 2013 the World 
Health Organization (WHO) adopted the Global Action Plan for the Prevention and Control 
of Noncommunicable Diseases for the period 2013-2020. This document addresses «the 
global action plan offers a paradigm shift by providing a road map and a menu of policy 
options for Member States, WHO, other UN organizations and intergovernmental 
organizations, NGOs and the private sector which, when implemented collectively between 
2013 and 2020, will attain 9 voluntary global targets, including that of a 25% relative 
reduction in premature mortality from NCDs by 2025 (7-9).  
Prevention of CVDs 
 
The position of the World Health Organization (WHO) is that over three quarters of the total 
mortality from CVDs can be prevented by appropriate changes in lifestyle. CVD prevention is 
7 
 
defined as a "coordinated set of activities at the public and individual levels, with the aim of 
eradicating, eliminating or reducing the significance of CVDs and their disabilities" (9). The 
scientific evidence collected over the last decades has confirmed the enormous importance of 
CVD prevention that must be lifelong, from childhood to old age. Furthermore, prevention is 
effective: by eliminating behavioral risk factors, it is possible to prevent at least 80% of CVDs 
and even 40% of cancers (24).  
An increased cardiovascular risk begins to develop in the early years of life. Even exposure to 
risk factors before birth can affect the risk of CVDs during their lifetime (25,26). Although 
children have a low absolute risk of developing CVDs, those with a relatively high risk 
compared to their peers, there remains an increased risk of cardiovascular events and later in 
life. A healthy lifestyle should begin as early as possible in childhood, creating healthy eating, 
eliminating smoking, regular physical activity, which will prevent or slow down the 
development of atherosclerosis (27). The two primary goals of promoting cardiovascular 
health in children are preventing the development of risk factors associated with 
atherosclerosis (primordial prevention) based on general measures that focus on respecting a 
healthy lifestyle, and the identification of a child at risk of developing early atherosclerosis 
due to the presence of identified risk factors, including hypertension, obesity, dyslipidemia, 
insulin resistance, physical inactivity, and exposure to tobacco smoke (28,29). However, in 
most countries, the majority of the prevention of CVD is still focused on middle-aged or older 
men and women with existing CVD (i.e. secondary prevention) or those at high risk for the 
development of first cardiovascular events (e.g. men and women with combinations of 
smoking, elevated blood pressure, diabetes or dyslipidemia (i.e. primary prevention).  
International experience has shown that the combinations of population strategies and 
strategies directed at high-risk individuals for CVDs are most effective (30). The population 
strategy aims to reduce the incidence of CVDs at the population level through a change in 
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lifestyle and environmental factors focused on the population as a whole. This strategy is 
primarily achieved through the establishment of ad-hoc policy and community-based 
activities. Examples include measures to stop smoking and reduce salt content in food. The 
advantage is that this method is of great benefit to the population. The impact of such an 
approach on the total number of CVDs in the population can be great, because all subjects are 
targeted and most of the events just appear in people who are at a moderate risk. Interventions 
consist of the promotion of a healthy lifestyle, healthy eating, physical activity, quitting 
smoking and drinking alcohol to a healthy environment (31). In a strategy targeting high-risk 
patients, preventive measures are aimed at reducing risk factors in those at the highest risk, 
whether they are individuals without CVDs at the upper percentiles of the total cardiovascular 
risk distribution or those with proven CVD. Interventions consist of CVD prevention in 
primary health care, hospitalization, specialized prevention programs, and alternative 
rehabilitation models (32). 
For a long time, the population strategy was considered more cost-effective than a strategy 
targeting high-risk patients, but since lipid lowering drugs have been introduced, programs for 
smoking cessation and a reduced price of antihypertensive drugs have been introduced, the 
effectiveness of a strategy targeting individuals at high risk is on the rise. Experience gained 
from long-term studies has reached a professional consensus: the greatest preventive effect in 
CVDs is achieved by combining the population and individual strategies (32,33). 
Overview of the CVD trends in Federation of Bosnia and 
Herzegovina 
 
The trends for the development of CVDs such as hypertension, smoking, alcohol 
consumption, diet, physical activity are monitored regularly through periodic population 
surveys conducted by the Public Health Institute of Federation of Bosnia and Herzegovina 
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(35). The results of the population surveys from recent years will be discussed below; in 
general, they confirm the expression of a large number of risk factors for the development of 
CVDs in all population groups in Federation of Bosnia and Herzegovina. 
In 2002, the Population Health Survey on Risk Factors for CVD was conducted as part of the 
World Bank project and with the expert support of the Public Health Institute of Finland. The 
results of this study have shown the widespread presence of cardiovascular risks in the 
population, hypertension in 41.0% of the population, obesity expressed as 21.5%, only 15.1% 
of the physically active population and 37.6% of smokers (34).  
In 2012, the Public Health Institute of the Federation of Bosnia and Herzegovina 
conducted a study that was supported by the World Bank on the health status of the 
population (35). This comprehensive analysis found an increase in risk factors for CVD 
development in Federation of Bosnia and Herzegovina. Briefly, the study reported that almost 
half of adults or 42.1% have hypertension or are undergoing treatment, of which 45.3% are 
men and 38.9% are women. Almost half of the adult population or 44.1% are smokers, of 
whom 56.3% are men and 31.6% are women. Over half of the population or 54.1% are 
exposed to tobacco smoke on a daily basis by other smokers in indoor public spaces. Among 
school children aged 13-15 years, 12.7% of smokers are recorded and nearly two thirds or 
60.7% of children state that they are exposed to passive smoking in indoor public spaces. 
Also, according to the same study, half of the adult population has a problem with inadequate 
nutrition, with 37.5% of the population being overweight and 22.5% obese. Physical activity 
is confirmed by a quarter of the population or 24.6% of population. 
The leading causes of death in Federation of Bosnia and Herzegovina in 2016 were 
diseases of the circulatory system (I00-I99) with a share of 53.1% of all causes (rate 508.2 / 
100.000 inhabitants) and recorded a slight decrease compared to 2010 when the share was 
53.8% with a rate of 472.1 / 100,000 inhabitants (36). Regarding general mortality, the rate in 
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2016 was 956.6 per 100,000 inhabitants, showing an increase compared to 2010, when it was 
876.2 per 100,000 inhabitants. And the standardized mortality rate for all causes and all ages 
for Federation of Bosnia and Herzegovina shows a significant increase in 2016, namely 952.2 
/ 100.000 inhabitants and almost equaled the general mortality rate.  
The data from 2016 listed myocardial infarction, stroke and heart failure as the three 
leading causes of death in Federation of Bosnia and Herzegovina. Deaths from the acute 
myocardial infarction had a rate of 91.0 / 100,000 inhabitants, which is a significant increase 
compared to 2010, when this rate was 69.2 / 100,000 inhabitants. The second leading cause of 
death, a stroke, with a rate of 87.1 / 100,000 inhabitants showed a slight decrease compared to 
2010, when it was 89.9. The third leading cause of death, a heart failure, with a rate of 68.4 / 
100.000 inhabitants, has a slight decrease compared to 2010, when the rate was 75.7 / 100.000 
inhabitants. The fourth cause of death was cardiomyopathy with the rate of 63.9 / 100.000 
inhabitants, which is less compared to 2010, when the rate was 78.7 / 100.000 inhabitants 
(36). 
 
Prevention and control of the CVDs in Federation of Bosnia and Herzegovina  
Several efforts were made by the health ministries in Federation of Bosnia and Herzegovina 
that focused on the prevention and control of CVDs will be discussed here. They emphasized 
the importance of preventing and controlling the risk factors for chronic NCDs including 
CVDs, because they are one of the main causes of mortality in Federation of Bosnia and 
Herzegovina (35). They reached a conclusion that was in accordance with international 
guidelines, namely to implement a strategy that consists of the population approach and the 
individual approach to high-risk individuals. This conclusion was in accordance with the 
reform of the Primary Health Care (PHC), which underwent major restructuring in the last 
decade through strengthening the concept of family or family medicine.  
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The PHC reform introduced the importance the prevention and control of risk factors for 
CVDs. Thus, in accordance with the current healthcare law, the family medicine team within 
the PHC provides continuous and comprehensive health care that is focused on the prevention 
and control of health factors and the early detection of disorders and diseases.  (38)  As part of 
the mentioned reform, the Federal Ministry of Health has revised the plan and program for 
doctors who specialize in family medicine by introducing additional continuing education for 
work in the family medicine team, in which certain services include prevention and control of 
risk factors for chronic diseases and CVDs (41). However, even with the reform of the PHC, 
several population-based research studies in Federation of Bosnia and Herzegovina pointed to 
inequalities in the availability of preventive healthcare for CVDs, because PHC is still 
therapeutically oriented and heavily burdened by administration (36).  
Several studies and projects were conducted regarding prevention of risk factors in Federation 
of Bosnia and Herzegovina. From 2005 to 2007, Institute of Public Health of the Federation 
of Bosnia and Herzegovina in cooperation with the Federal Ministry of Health with the 
support of the Health Insurance Institute of Federation of Bosnia and Herzegovina, conducted 
a pilot project focused on five risk factors (hypertension, obesity, unhealthy diet, smoking and 
physical activity). The project was implemented through the work of 40 teams of family 
medicine in the Sarajevo Canton and the West Herzegovina Canton (41,42).  
In the period from 2013 to 2017, the project "Strengthening and improving modern and 
sustainable public health strategies, capacities and services for improving the health of the 
population in Bosnia and Herzegovina" was launched in partnership with the Swiss Agency 
for Development and Cooperation (SDC), in order to support interventions in the prevention 
and control of chronic diseases in Bosnia and Herzegovina, and the WHO Regional Office for 
Europe. The implementation of activities under this Project in Federation of Bosnia and 
Herzegovina has been entrusted to the Public Health Institute of Federation of Bosnia and 
12 
 
Herzegovina in cooperation with the Federal Ministry of Health. Through component 2 of this 
Project, titled: "Adjustment / development of instruments, materials and sets of indicators for 
implementation, monitoring and evaluation of interventions from the domain of risk 
assessment and CVD management (CVRAM), initiated the activities of assessing the overall 
cardiovascular risk in the practice of family medicine, development of guidelines  and 
protocols as procedures family medicine teams  related to CVDs and risk factors, and the 
development of adequate educational materials for patients (41,42). 
Currently, an international project on Oral and Cardiovascular Health has been initiated the 
Committee for Cardiovascular Pathology of the Department of Medical Sciences of the 
Academy of Science of Bosnia and Herzegovina. This ongoing project will provide a good 
basis for planning systemic interventions of prevention of CVDs in Bosnia and Herzegovina. 
Since the control of CVDs requires an adequate system of healthcare and statistical reporting, 
the Public Health Institute of Federation of Bosnia and Herzegovina , in cooperation with the 
Federal Ministry of Health, initiated  activities on the reform of the healthcare statistical 
system (HSS) with the aim of harmonization with internationally recommended indicators. 
The registry for CVDs at the federal and state levels has not yet been established, while the 
development of the diabetes registry is still in the initial phase. From 2012 to 2014, Federal 
Ministry of Health supported by the World Bank, created a study named Health Sector 
Strengthening Project that was implemented through family medicine teams with the aim of 
affirming the approach to screening of risk factors for patients aged 45-65 in the Federation of 
Bosnia and Herzegovina. The aim of the project was  to develop adequate records and 
medical documentation mechanisms that should serve as the basis for improving the existing 
system of health statistical records (41,42). 
Health budgets in Federation of Bosnia and Herzegovina cover the enormous costs of 
diagnosing and treating CVDs, while prevention and promotion of health are still viewed as 
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an additional cost rather than a long-term and cost-effective investment in the health of 
citizens. Thus, according to the data of the Health Insurance Fund of Federation of Bosnia and 
Herzegovina, the number of patients who used cardiac and cardiovascular health services 
recorded steady growth from 4358 in 2011 to 5379 in 2015 as well as an increase in costs for 
these services in the amount of BAM  21,511,222 in 2011 to 25,140,839 KM in 2015 (41).  
In order to raise awareness among citizens about the importance of a healthy life by avoiding 
risk factors, the particular problem is the lack of continuous and intersectoral health 
promotion campaigns in Bosnia and Herzegovina, due in part to inadequate coordination 
between the sectors, mainly due to inadequate sources of funding. Less promotional 
interventions are implemented periodically by health institutions, public health institutes, civil 
society, but this is still insufficient. Despite long public health advocacy efforts to divert part 
of the high tax tariffs, such as tobacco products into the health sector to finance systemic 
health promotion interventions, this intervention has not enforced  in Bosnia and 
Herzegovina. 
 
Guidelines for CVDs in Federation of Bosnia and Herzegovina  
 
Over the past years, a number of project activities have been initiated in the health sector of 
Federation of Bosnia and Herzegovina, through the support of relevant international 
organizations, which have been aimed at providing the basis for effective CVDs management. 
Within the framework of the project "Strengthening and improving modern and sustainable 
public health strategies, capacities and services for improving the health of the population in 
Bosnia and Herzegovina" in partnership with the Swiss Agency for Development and 
Cooperation (SDC), the Public Health Institute, Federal Ministry of Health and Association of 
cardiologists of Bosnia and Herzegovina have published guidelines for: diseases and 
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cardiovascular risks, hypertension, diabetes and dyslipidemia as well as also protocols for 
individual risk factors such as obesity in children and adults, physical activity of diabetes and 
smoking, using the European Guide for the Prevention of CVDs in Clinical Practice (2012 
version), developed by the European Society for Cardiovascular Prevention and 
Rehabilitation (EACPR). 
In order to support the effective use of these guidelines and guidelines for the prevention and 
control of CVDs, in 2017 about 1200 medical doctors and nurses in family medicine teams in 
Federation of Bosnia and Herzegovina participated in the education that introduced and 
explained the importance of the mentioned guidelines. The education was organized by the 
Public Health Institute of Federation of Bosnia and Herzegovina in cooperation with the 
education centers of family medicine of the Health Centers in Sarajevo, Tuzla, Zenica, Mostar 
and Bihać. 
 
Discussion  
CVDs have become a global public health challenge. As such, numerous efforts have been 
initiated by UN and WHO to emphasize the importance of prevention and control of CVDs 
globally. The Moscow Declaration on Noncommunicable Diseases and UN Political 
Declaration on Non-communicable Diseases have highlighted international co-operation and 
national efforts in the prevention of risk factors and in reducing disease and mortality from 
chronic diseases (5,6). WHO adopted the Global Action Plan for the Prevention and Control 
of Noncommunicable Diseases for the period 2013-2020, which is going to meet the 
achievement of 9 global for non-communicable diseases that the Member States committed 
by 2025 through the development and implementation of national policies, strategies and 
action plans to combat mortality from non-communicable diseases, and in particular to CVDs 
(7-9). 
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All scientific evidence collected through studies in recent decades has confirmed the 
enormous significance of CVDs prevention that must be lifelong, which begins during 
pregnancy and lasts for the rest of their lives because an increased cardiovascular risk begins 
to develop in the early years of life. Even exposure to risk factors before birth can affect the 
risk of CVD during life (43,44). A healthy lifestyle should begin as early as possible in 
childhood, by creating healthy eating, eliminating smoking, alcohol, regular physical activity, 
and regular blood pressure, blood sugar and blood lipid control, which can prevent or slow 
down the development of atherosclerosis as a risk factor for the development of CVDs (45-
48). 
The recommendations contained in European Guidelines for CVDs point out that the greatest 
preventive effect is achieved by combining a population strategy and strategy directed at high-
risk individuals. The population strategy aims to reduce the incidence of CVDs at the 
population level through a change in lifestyle and environmental factors focused on the 
population as a whole. Interventions consist of the promotion of a healthy lifestyle, healthy 
eating, and physical activity, quitting smoking and drinking alcohol to a healthy environment. 
In a strategy targeting high-risk patients, preventive measures are aimed at reducing risk 
factors for individuals at high risk for CVD or those with proven CVDs. 
 
Conclusion 
CVD (CVDs) is the leading cause of mortality among the population of Federation of Bosnia 
and Herzegovina, which, in addition to the large number of premature deaths, also causes 
major costs for the health sector and the community as a whole. The monitoring of trends of 
CVDs  in Bosnia and Herzegovina is carried out through regular health statistics and periodic 
population surveys, with still a clear need to initiate a register for the CVDs  in Bosnia and 
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Herzegovina, in order to gain a more complete insight into the dimensions of this public 
health problem. 
Over the recent years, in the health sector in Federation of Bosnia and Herzegovina, numerous 
activities have been initiated with the aim of curbing the CVDs, which often remained after 
the completion of project initiatives remained limited to the level of individual cantons or 
healthcare institutions. With the aim of supporting the systematic harmonization of the 
prevention and control measures of the CVDs in Federation of Bosnia and Herzegovina, in the 
period from 2013 to 2017, the activities of the assessment of overall cardiovascular risk in 
family medicine have been initiated, and on the basis of good international practice, guideline 
for CVDs have been published and guidelines for leading risk factors for CVDs. 
As it has been proven that exposure to risk factors before birth can affect the risk of CVD 
during the lifetime, CVDs prevention must be of a lifelong type, with the onset and during 
pregnancy until the end of life, in order to alleviate CVDs outcomes. International research is 
under way on Oral and Cardiovascular Health, within the activities of the Committee for 
Cardiovascular Pathology of the Department of Medical Sciences of the Academy of Science 
of Bosnia and Herzegovina, which results will surely provide good basis for planning 
systemic interventions of prevention of CVDs in Bosnia and Herzegovina. 
In further strengthening of the systematic prevention of risk factors for CVDs and developing 
the concept of health promotion, more efficient coordination and active participation of 
relevant institutions is needed, from the ministries of health, public health institutes, all levels 
of health care with a special focus on PHC and family medicine teams, to the educational 
institutions at all levels and the patient association. 
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